Dengue Moment
For a country that has lived with dengue as a seasonal inevitability, the emergence of DengiAll, India’s indigenous single-shot dengue vaccine now in advanced trials in Delhi, is more than a scientific milestone.
For a country that has lived with dengue as a seasonal inevitability, the emergence of DengiAll, India’s indigenous single-shot dengue vaccine now in advanced trials in Delhi, is more than a scientific milestone.
The World Health Organization (WHO) has donated 2,160 doses of Ebola trial vaccine to Uganda to evaluate the efficacy of the vaccine in combating the virus which in the recent outbreak has killed a health worker in Kampala, the country's capital.
Indonesia is developing a new Tuberculosis (TB) vaccine to strengthen the fight against TB, which has claimed an average of 150,000 lives annually.
The landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec.
Specifically, the team compared the immune responses in people who were protected against CMV infection after receiving the older vaccine.
Given the quickly changing scene of the pandemic worldwide, experts say that the best protection against high-risk individuals is the one at hand.
Hepatitis is an inflammation of the liver. There are five main types of the hepatitis virus – A, B, C, D and E. Hepatitis B and C lead to chronic disease in hundreds of millions of people globally.
Seamless integration of automation solutions makes it possible to develop, optimize, and manage production processes efficiently.
The WHO has also issued new guidelines on monkeypox vaccination, which includes recommendations on use of (smallpox) vaccines for monkeypox.
According to the Ministry, the doses have been administered to the Health Care Workers (HCWs) whereas 1,84,14,942 (1st Dose), 1,75,32,038 (2nd Dose), and 73,40,412 (Precaution Dose) have been jabbed to the Front Line Workers (FLWs) in the country.
